Detailed answers about NAD HEALTH GROUP CO., LIMITED, including incorporation, status, business activity, and accounts information.
When was NAD HEALTH GROUP CO., LIMITED founded?
NAD HEALTH GROUP CO., LIMITED was officially incorporated on 30 January 2026 and is registered under company number 17002173. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NAD HEALTH GROUP CO., LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NAD HEALTH GROUP CO., LIMITED?
NAD HEALTH GROUP CO., LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NAD HEALTH GROUP CO., LIMITED do?
NAD HEALTH GROUP CO., LIMITED operates in the following sectors: 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c., 47910 - Retail sale via mail order houses or via Internet, 72110 - Research and experimental development on biotechnology, 79110 - Travel agency activities. These SIC codes provide insight into the company's business activities and industry focus.
What is NAD HEALTH GROUP CO., LIMITED's registered address?
The registered office address of NAD HEALTH GROUP CO., LIMITED is OFFICE SUITE 29A, 3/F.,, 23 WHARF STREET, LONDON, ENGLAND, SE8 3GG. This is the official address filed with Companies House for legal and statutory correspondence.
Is NAD HEALTH GROUP CO., LIMITED financially stable?
Financial accounts for NAD HEALTH GROUP CO., LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.